Literature DB >> 25626710

Homozygous Truncating Intragenic Duplication in TUSC3 Responsible for Rare Autosomal Recessive Nonsyndromic Intellectual Disability with No Clinical or Biochemical Metabolic Markers.

S El Chehadeh1, C Bonnet, P Callier, M Béri, T Dupré, M Payet, C Ragon, A L Mosca-Boidron, N Marle, F Mugneret, A Masurel-Paulet, J Thevenon, N Seta, L Duplomb, P Jonveaux, L Faivre, C Thauvin-Robinet.   

Abstract

Intellectual disability (ID), which affects around 2-3% of the general population, is classically divided into syndromic and nonsyndromic forms, with several modes of inheritance. Nonsyndromic autosomal recessive ID (NS-ARID) appears extremely heterogeneous with numerous genes identified to date, including inborn errors of metabolism. The TUSC3 gene encodes a subunit of the endoplasmic reticulum (ER)-bound oligosaccharyltransferase complex, which mediates a key step of N-glycosylation. To date, only five families with NS-ARID and TUSC3 mutations or rearrangements have been reported in the literature. All patients had speech delay, moderate-to-severe ID, and moderate facial dysmorphism. Microcephaly was noted in one third of patients, as was short stature. No patients had congenital malformation except one patient with unilateral cryptorchidism. Glycosylation analyses of patients' fibroblasts showed normal N-glycan synthesis and transfer. We present a review of the 19 patients previously described in the literature and report on a sixth consanguineous family including two affected sibs, with intellectual disability, unspecific dysmorphic features, and no additional malformations identified by high-resolution array-CGH. A homozygous truncating intragenic duplication of the TUSC3 gene leading to an aberrant transcript was detected in two siblings. This observation, which is the first reported case of TUSC3 homozygous duplication, confirms the implication of TUSC3 in NS-ARID and the power of the high-resolution array-CGH in identifying intragenic rearrangements of genes implicated in nonsyndromic ID and rare diseases.

Entities:  

Year:  2015        PMID: 25626710      PMCID: PMC4375127          DOI: 10.1007/8904_2014_390

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  25 in total

Review 1.  Genetics of intellectual disability.

Authors:  H Hilger Ropers
Journal:  Curr Opin Genet Dev       Date:  2008-08-28       Impact factor: 5.578

2.  Enhancement of learning and memory by elevating brain magnesium.

Authors:  Inna Slutsky; Nashat Abumaria; Long-Jun Wu; Chao Huang; Ling Zhang; Bo Li; Xiang Zhao; Arvind Govindarajan; Ming-Gao Zhao; Min Zhuo; Susumu Tonegawa; Guosong Liu
Journal:  Neuron       Date:  2010-01-28       Impact factor: 17.173

3.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study.

Authors:  Anita Rauch; Dagmar Wieczorek; Elisabeth Graf; Thomas Wieland; Sabine Endele; Thomas Schwarzmayr; Beate Albrecht; Deborah Bartholdi; Jasmin Beygo; Nataliya Di Donato; Andreas Dufke; Kirsten Cremer; Maja Hempel; Denise Horn; Juliane Hoyer; Pascal Joset; Albrecht Röpke; Ute Moog; Angelika Riess; Christian T Thiel; Andreas Tzschach; Antje Wiesener; Eva Wohlleber; Christiane Zweier; Arif B Ekici; Alexander M Zink; Andreas Rump; Christa Meisinger; Harald Grallert; Heinrich Sticht; Annette Schenck; Hartmut Engels; Gudrun Rappold; Evelin Schröck; Peter Wieacker; Olaf Riess; Thomas Meitinger; André Reis; Tim M Strom
Journal:  Lancet       Date:  2012-09-27       Impact factor: 79.321

4.  Diagnostic value of Western blotting in carbohydrate-deficient glycoprotein syndrome.

Authors:  N Seta; A Barnier; F Hochedez; M A Besnard; G Durand
Journal:  Clin Chim Acta       Date:  1996-10-29       Impact factor: 3.786

5.  Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient.

Authors:  Sara Loddo; Valentina Parisi; Viola Doccini; Tiziana Filippi; Laura Bernardini; Paola Brovedani; Federica Ricci; Antonio Novelli; Agatino Battaglia
Journal:  Am J Med Genet A       Date:  2013-07-04       Impact factor: 2.802

Review 6.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

Review 7.  An evolving view of the eukaryotic oligosaccharyltransferase.

Authors:  Daniel J Kelleher; Reid Gilmore
Journal:  Glycobiology       Date:  2005-11-29       Impact factor: 4.313

8.  Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties.

Authors:  Daniel J Kelleher; Denise Karaoglu; Elisabet C Mandon; Reid Gilmore
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

9.  A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disability.

Authors:  Muzammil Ahmad Khan; Muhammad Arshad Rafiq; Abdul Noor; Nadir Ali; Ghazanfar Ali; John B Vincent; Muhammad Ansar
Journal:  BMC Med Genet       Date:  2011-04-22       Impact factor: 2.103

Review 10.  Biological roles of oligosaccharides: all of the theories are correct.

Authors:  A Varki
Journal:  Glycobiology       Date:  1993-04       Impact factor: 4.313

View more
  4 in total

Review 1.  N-linked glycosylation and homeostasis of the endoplasmic reticulum.

Authors:  Natalia Cherepanova; Shiteshu Shrimal; Reid Gilmore
Journal:  Curr Opin Cell Biol       Date:  2016-04-14       Impact factor: 8.382

2.  TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.

Authors:  Zhenfeng Jiang; Mian Guo; Xiangtong Zhang; Lifen Yao; Jia Shen; Guizhen Ma; Li Liu; Liwei Zhao; Chuncheng Xie; Hongsheng Liang; Haiyang Wang; Minwei Zhu; Li Hu; Yuanyuan Song; Hong Shen; Zhiguo Lin
Journal:  Tumour Biol       Date:  2016-05-13

Review 3.  TUSC3: a novel tumour suppressor gene and its functional implications.

Authors:  Xinshuang Yu; Chunjuan Zhai; Yujun Fan; Jiandong Zhang; Ning Liang; Fengjun Liu; Lili Cao; Jia Wang; Juan Du
Journal:  J Cell Mol Med       Date:  2017-03-08       Impact factor: 5.310

4.  A Homozygous 1.16 Megabases Microdeletion at 8p22 Including The Whole TUSC3 in A Three Years Old Girl with Intellectual Disability and Speech Delay.

Authors:  Evren Gumus
Journal:  Cell J       Date:  2019-09-08       Impact factor: 2.479

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.